RxSight Net Common Equity Issued/Repurchased 2021-2024 | RXST
RxSight Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
---|---|
2024 | $129 |
2023 | $106 |
2022 | $8 |
2021 | $121 |
2020 | $1 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $0.644B | $0.140B |
RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif. |